Results 21 to 30 of about 484,489 (312)

High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany

BMC Public Health, 2017
Background In Germany, medical care of prisoners is completely separated from extramural health care. The extent and quality of medical care among prisoners in Germany are therefore largely unknown.
Jana Müller, Daniel Schmidt, Christian Kollan, Marc Lehmann, Viviane Bremer, Ruth Zimmermann   +5 more
doaj   +1 more source

High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011–2014: missed opportunities for hepatitis C testing

Harm Reduction Journal, 2020
Background In Germany, risk of hepatitis C virus (HCV) infection is highest among people who inject drugs (PWID). New injectors (NI) are particularly vulnerable for HCV-acquisition, but little is known about health seeking behaviour and opportunities for
Julia Enkelmann, Martyna Gassowski, Stine Nielsen, Benjamin Wenz, Stefan Roß, Ulrich Marcus, Viviane Bremer, Ruth Zimmermann, DRUCK Study group   +8 more
doaj   +1 more source

Trends in Neisseria gonorrhoeae Antimicrobial Resistance over a Ten-Year Surveillance Period, Johannesburg, South Africa, 2008–2017

Antibiotics, 2018
Background: In South Africa, sexually transmitted infections (STIs) are managed through a syndromic approach at primary healthcare centres (PHCs). Neisseria gonorrhoeae is the predominant cause of male urethritis syndrome.
Ranmini Kularatne, Venessa Maseko, Lindy Gumede, Tendesayi Kufa   +3 more
doaj   +1 more source

Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007–2014

BMC Infectious Diseases, 2019
Background Antimicrobial resistance in Mycoplasma genitalium is rising globally with resultant clinical treatment failure. We investigated the prevalence of mutations in the macrolide and fluoroquinolone resistance-determining regions of M. genitalium in
Etienne E. Muller, Mahlape P. Mahlangu, David A. Lewis, Ranmini S. Kularatne   +3 more
doaj   +1 more source

Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021

Frontiers in Public Health, 2023
Effectively treating hepatitis C viral (HCV) infections prevents sequelae and onward transmission. In Germany, HCV drug prescriptions have declined since 2015.
Emily D. Meyer, Emily D. Meyer, Sandra Dudareva, Christian Kollan, Stefan Mauss, Heiner Wedemeyer, Daniel Schmidt, Ruth Zimmermann   +7 more
doaj   +1 more source

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017–2020

BMC Infectious Diseases, 2023
Background The transmission of resistant HIV variants jeopardizes the effective use of antiretrovirals for therapy and prophylaxis. Molecular surveillance of new HIV diagnoses with a focus on prevalence and type of resistance associated mutations and the
Uwe Fiebig, Britta Altmann, Andrea Hauser, Uwe Koppe, Kirsten Hanke, Barbara Gunsenheimer-Bartmeyer, Viviane Bremer, Axel Baumgarten, Norbert Bannert   +8 more
doaj   +1 more source

Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review

BMC Public Health, 2021
Background Despite remarkable achievements in antiretroviral therapy (ART), losses to follow-up (LTFU) might prevent the long-term success of HIV treatment and might delay the achievement of the 90–90-90 objectives.
Jorge Palacio-Vieira, Juliana Maria Reyes-Urueña, Arkaitz Imaz, Andreu Bruguera, Luis Force, Amat Orti Llaveria, Josep M. Llibre, Ingrid Vilaró, Francesc Homar Borràs, Vicenç Falcó, Melchor Riera, Pere Domingo, Elisa de Lazzari, Josep M. Miró, Jordi Casabona, PICIS study group   +15 more
doaj   +1 more source

High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011–14)

BMC Public Health, 2016
Background People who inject drugs (PWID) are at increased risk of acquiring and transmitting HIV and Hepatitis C (HCV) due to sharing injection paraphernalia and unprotected sex. To generate seroprevalence data on HIV and HCV among PWID and related data
Benjamin Wenz, Stine Nielsen, Martyna Gassowski, Claudia Santos-Hövener, Wei Cai, R. Stefan Ross, Claus-Thomas Bock, Boris-Alexander Ratsch, Claudia Kücherer, Norbert Bannert, Viviane Bremer, Osamah Hamouda, Ulrich Marcus, Ruth Zimmermann, the DRUCK Study group   +14 more
doaj   +1 more source

Evidence synthesis evaluating body weight gain among people treating HIV with antiretroviral therapy - a systematic literature review and network meta-analysis

EClinicalMedicine, 2022
Summary: Background: This systematic review aimed to compare body weight gain associated outcomes over time between dolutegravir (DTG)-based antiretroviral (ART) regimens to other ART regimens, to compare tenofovir alafenamide (TAF)-based regimens, and ...
Steve Kanters, Francoise Renaud, Ajay Rangaraj, Kenneth Zhang, Eve Limbrick-Oldfield, Monica Hughes, Nathan Ford, Marco Vitoria   +7 more
doaj   +1 more source

Impact of health insurance status among migrants from sub-Saharan Africa on access to health care and HIV testing in Germany: a participatory cross-sectional survey

BMC International Health and Human Rights, 2019
Background Among all newly diagnosed HIV cases in Germany in 2015, 16% originated from sub-Saharan Africa. Twelve percent of these infections were contracted within Germany and migrants from sub-Saharan Africa (misSA) are diagnosed later than Germans ...
Johanna Müllerschön, Carmen Koschollek, Claudia Santos-Hövener, Anna Kuehne, Jacqueline Müller-Nordhorn, Viviane Bremer   +5 more
doaj   +1 more source